Tumor-infiltrating lymphocyte expansion protocols for adoptive cell therapy in cancer.
Saved in:
| Title: | Tumor-infiltrating lymphocyte expansion protocols for adoptive cell therapy in cancer. |
|---|---|
| Authors: | Tovar Manzano D; Department of Clinical Immunology, Unidad de Inmunomonitorización del Cáncer y de Patologías Inmunomediadas (UICPI), Hospital Clínico San Carlos, IdISSC, Madrid, 28040, Spain.; Department Immunology, Ophthalmology, and ORL, School of Medicine, Complutense University, Madrid, 28040, Spain., Subhi-Issa N; Department of Clinical Immunology, Unidad de Inmunomonitorización del Cáncer y de Patologías Inmunomediadas (UICPI), Hospital Clínico San Carlos, IdISSC, Madrid, 28040, Spain., Pereiro-Rodríguez A; Department of Clinical Immunology, Unidad de Inmunomonitorización del Cáncer y de Patologías Inmunomediadas (UICPI), Hospital Clínico San Carlos, IdISSC, Madrid, 28040, Spain., López Cade IG; Experimental Therapeutics Unit, Department of Medical Oncology, Hospital Clínico San Carlos, IdISSC, Madrid, 28040, Spain., Mateos González M; Department of Medical Oncology, Hospital Clínico San Carlos, IdISSC, Madrid, 28040, Spain., Fernández Arquero M; Department of Clinical Immunology, Unidad de Inmunomonitorización del Cáncer y de Patologías Inmunomediadas (UICPI), Hospital Clínico San Carlos, IdISSC, Madrid, 28040, Spain.; Department Immunology, Ophthalmology, and ORL, School of Medicine, Complutense University, Madrid, 28040, Spain., Pérez Segura P; Department of Medical Oncology, Hospital Clínico San Carlos, IdISSC, Madrid, 28040, Spain.; Experimental Therapeutics Unit, Department of Medical Oncology, Hospital Clínico San Carlos, IdISSC, Madrid, 28040, Spain., Ujaldón Miró C; Cell Therapy Unit, Clean Room, Hospital Clínico San Carlos, IdISSC, Madrid, 28040, Spain., Sánchez-Ramón S; Department of Clinical Immunology, Unidad de Inmunomonitorización del Cáncer y de Patologías Inmunomediadas (UICPI), Hospital Clínico San Carlos, IdISSC, Madrid, 28040, Spain.; Department Immunology, Ophthalmology, and ORL, School of Medicine, Complutense University, Madrid, 28040, Spain., Ocaña A; Department of Medical Oncology, Hospital Clínico San Carlos, IdISSC, Madrid, 28040, Spain.; Experimental Therapeutics Unit, Department of Medical Oncology, Hospital Clínico San Carlos, IdISSC, Madrid, 28040, Spain., Guzmán Fulgencio M; Department of Clinical Immunology, Unidad de Inmunomonitorización del Cáncer y de Patologías Inmunomediadas (UICPI), Hospital Clínico San Carlos, IdISSC, Madrid, 28040, Spain. mguzmanf@salud.madrid.org. |
| Source: | Cellular oncology (Dordrecht, Netherlands) [Cell Oncol (Dordr)] 2025 Dec; Vol. 48 (6), pp. 1659-1675. Date of Electronic Publication: 2025 Nov 17. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Country of Publication: Netherlands NLM ID: 101552938 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-3436 (Electronic) Linking ISSN: 22113428 NLM ISO Abbreviation: Cell Oncol (Dordr) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2211-3436 |
|---|---|
| DOI: | 10.1007/s13402-025-01112-2 |
